Related Experiment Videos
Studies on the interaction between cytochrome c and cis-PtCl2(NH3)2
1State Key Laboratory of Coordination Chemistry, Nanjing University, People's Republic of China.
Journal of Inorganic Biochemistry
|February 1, 1997
Summary
Cisplatin (cis-PtCl2(NH3)2) selectively binds to sulfur in cytochrome c, differing from PtCl4(2-) interactions. This platinum-protein binding was characterized using various spectroscopic and electrochemical methods.
Area of Science:
- Biochemistry
- Metalloprotein interactions
- Platinum-based therapeutics
Background:
- Cytochrome c is a crucial protein in cellular respiration.
- Platinum complexes, like cisplatin, are widely used in cancer chemotherapy.
- Understanding drug-protein interactions is vital for drug development.
Purpose of the Study:
- To investigate the interaction between cisplatin and cytochrome c.
- To determine the binding selectivity and mode of cisplatin with cytochrome c.
- To compare the binding of cisplatin with that of PtCl4(2-) to cytochrome c.
Main Methods:
- Spectroscopic techniques (1H NMR, UV-vis) were employed.
- Differential pulse voltammetry was used for electrochemical analysis.
- Molar ratio analysis of platinum and iron atoms characterized binding sites.
Main Results:
- Cisplatin selectively binds to methionine residues (containing sulfur) in cytochrome c.
- The binding mode of cisplatin differs significantly from that of PtCl4(2-).
- Binding sites were successfully identified and characterized.
Conclusions:
- Cisplatin exhibits high selectivity for sulfur-containing residues in cytochrome c.
- The distinct binding interaction of cisplatin with cytochrome c has implications for its biological activity.
- This study provides insights into the molecular mechanisms of platinum-drug interactions with proteins.